Currently prescribed drugs in the UK that could up or downregulate ACE2 in COVID-19 disease: A systematic review (2020)

First Author: Dambha-Miller H
Attributed to:  Prevention of Diabetes and Related Metabolic Disorders in High Risk Groups funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.56235

Publication URI: https://www.repository.cam.ac.uk/handle/1810/309138

Type: Journal Article/Review